{"id":"https://openalex.org/W2076901284","doi":"https://doi.org/10.1007/s11064-007-9429-3","title":"Anticonvulsant Efficacy of Drugs with Cholinergic and/or Glutamatergic Antagonism Microinfused into Area Tempestas of Rats Exposed to Soman","display_name":"Anticonvulsant Efficacy of Drugs with Cholinergic and/or Glutamatergic Antagonism Microinfused into Area Tempestas of Rats Exposed to Soman","publication_year":2007,"publication_date":"2007-08-20","ids":{"openalex":"https://openalex.org/W2076901284","doi":"https://doi.org/10.1007/s11064-007-9429-3","mag":"2076901284","pmid":"https://pubmed.ncbi.nlm.nih.gov/17710542"},"language":"en","primary_location":{"id":"doi:10.1007/s11064-007-9429-3","doi":"https://doi.org/10.1007/s11064-007-9429-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11064-007-9429-3","pdf_url":null,"source":{"id":"https://openalex.org/S174790897","display_name":"Neurochemical Research","issn_l":"0364-3190","issn":["0364-3190","1573-6903"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurochemical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035293135","display_name":"Trond Myhrer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163244428","display_name":"Norwegian Defence Research Establishment","ror":"https://ror.org/0098gnz32","country_code":"NO","type":"facility","lineage":["https://openalex.org/I163244428"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Trond Myhrer","raw_affiliation_strings":["Norwegian Defence Research Establishment, Protection Division, P.O. Box 25, 2027 Kjeller, Norway. trond.myhrer@ffi.no","Norwegian Defence Research Establishment, Protection Division"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norwegian Defence Research Establishment, Protection Division, P.O. Box 25, 2027 Kjeller, Norway. trond.myhrer@ffi.no","institution_ids":["https://openalex.org/I163244428"]},{"raw_affiliation_string":"Norwegian Defence Research Establishment, Protection Division","institution_ids":["https://openalex.org/I163244428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061448826","display_name":"Siri Enger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163244428","display_name":"Norwegian Defence Research Establishment","ror":"https://ror.org/0098gnz32","country_code":"NO","type":"facility","lineage":["https://openalex.org/I163244428"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Siri Enger","raw_affiliation_strings":["Norwegian Defence Research Establishment, Protection Division, P.O. Box 25, 2027, Kjeller, Norway","Norwegian Defence Research Establishment, Protection Division"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norwegian Defence Research Establishment, Protection Division, P.O. Box 25, 2027, Kjeller, Norway","institution_ids":["https://openalex.org/I163244428"]},{"raw_affiliation_string":"Norwegian Defence Research Establishment, Protection Division","institution_ids":["https://openalex.org/I163244428"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023330531","display_name":"P\u00e5l Aas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I163244428","display_name":"Norwegian Defence Research Establishment","ror":"https://ror.org/0098gnz32","country_code":"NO","type":"facility","lineage":["https://openalex.org/I163244428"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"P\u00e5l Aas","raw_affiliation_strings":["Norwegian Defence Research Establishment, Protection Division, P.O. Box 25, 2027, Kjeller, Norway","Norwegian Defence Research Establishment, Protection Division"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Norwegian Defence Research Establishment, Protection Division, P.O. Box 25, 2027, Kjeller, Norway","institution_ids":["https://openalex.org/I163244428"]},{"raw_affiliation_string":"Norwegian Defence Research Establishment, Protection Division","institution_ids":["https://openalex.org/I163244428"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035293135"],"corresponding_institution_ids":["https://openalex.org/I163244428"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":1.9862,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.8569317,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"33","issue":"2","first_page":"348","last_page":"354"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8467000126838684,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.8467000126838684,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10875","display_name":"Pesticide Exposure and Toxicity","score":0.11949999630451202,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soman","display_name":"soman","score":0.9629999995231628},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8389999866485596},{"id":"https://openalex.org/keywords/antiparkinsonian-drugs","display_name":"antiparkinsonian drugs","score":0.7910000085830688},{"id":"https://openalex.org/keywords/cholinergic-antagonism","display_name":"cholinergic antagonism","score":0.828000009059906},{"id":"https://openalex.org/keywords/microinfusion","display_name":"microinfusion","score":0.7609999775886536},{"id":"https://openalex.org/keywords/procyclidine","display_name":"procyclidine","score":0.968999981880188},{"id":"https://openalex.org/keywords/atropine","display_name":"atropine","score":0.8080000281333923},{"id":"https://openalex.org/keywords/scopolamine","display_name":"scopolamine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/mk-801","display_name":"MK-801","score":0.8489999771118164},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/countermeasures","display_name":"countermeasures","score":0.5910000205039978},{"id":"https://openalex.org/keywords/clonic-convulsions","display_name":"clonic convulsions","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C2780266723","wikidata":"https://www.wikidata.org/wiki/Q408044","display_name":"Soman","level":4,"score":0.9350703954696655},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.7661786079406738},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7339275479316711},{"id":"https://openalex.org/C2779406339","wikidata":"https://www.wikidata.org/wiki/Q2991856","display_name":"Trihexyphenidyl","level":2,"score":0.7199617624282837},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.6126666069030762},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.6116112470626831},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.5342176556587219},{"id":"https://openalex.org/C22885893","wikidata":"https://www.wikidata.org/wiki/Q4862743","display_name":"Cholinergic","level":2,"score":0.5122038722038269},{"id":"https://openalex.org/C2776291473","wikidata":"https://www.wikidata.org/wiki/Q3363684","display_name":"Parasympatholytic","level":4,"score":0.47054749727249146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.453889399766922},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.43939918279647827},{"id":"https://openalex.org/C2775859210","wikidata":"https://www.wikidata.org/wiki/Q26272","display_name":"Atropine","level":2,"score":0.436867892742157},{"id":"https://openalex.org/C2781011581","wikidata":"https://www.wikidata.org/wiki/Q421301","display_name":"Felbamate","level":4,"score":0.4179578125476837},{"id":"https://openalex.org/C33789571","wikidata":"https://www.wikidata.org/wiki/Q410959","display_name":"Muscarinic acetylcholine receptor","level":3,"score":0.3299647867679596},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.30547916889190674},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.26176029443740845},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.2530967593193054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1847417950630188},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.1416831612586975},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011950","descriptor_name":"Receptors, Cholinergic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012999","descriptor_name":"Soman","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017470","descriptor_name":"Receptors, Glutamate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018680","descriptor_name":"Cholinergic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s11064-007-9429-3","doi":"https://doi.org/10.1007/s11064-007-9429-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11064-007-9429-3","pdf_url":null,"source":{"id":"https://openalex.org/S174790897","display_name":"Neurochemical Research","issn_l":"0364-3190","issn":["0364-3190","1573-6903"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurochemical Research","raw_type":"journal-article"},{"id":"pmid:17710542","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17710542","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurochemical research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W54076119","https://openalex.org/W92838330","https://openalex.org/W1489003835","https://openalex.org/W1707439038","https://openalex.org/W1954401748","https://openalex.org/W1965302612","https://openalex.org/W1969047674","https://openalex.org/W1977733508","https://openalex.org/W1978770413","https://openalex.org/W1983282357","https://openalex.org/W1986607212","https://openalex.org/W1997633644","https://openalex.org/W2002608596","https://openalex.org/W2014459302","https://openalex.org/W2017566530","https://openalex.org/W2031734276","https://openalex.org/W2034887080","https://openalex.org/W2039860211","https://openalex.org/W2040399114","https://openalex.org/W2044882534","https://openalex.org/W2049381848","https://openalex.org/W2052072990","https://openalex.org/W2070840066","https://openalex.org/W2076323101","https://openalex.org/W2079257658","https://openalex.org/W2079725109","https://openalex.org/W2081319561","https://openalex.org/W2082480382","https://openalex.org/W2095822972","https://openalex.org/W2109674931","https://openalex.org/W2134801846","https://openalex.org/W2162582135","https://openalex.org/W2207979588","https://openalex.org/W2399595378","https://openalex.org/W2409202073"],"related_works":["https://openalex.org/W2041740977","https://openalex.org/W1988321110","https://openalex.org/W1969047674","https://openalex.org/W2079257658","https://openalex.org/W2014459302","https://openalex.org/W2028986241","https://openalex.org/W2072988210","https://openalex.org/W3178408747","https://openalex.org/W2391301450","https://openalex.org/W2005007290"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}